Recent developments with Alzamend Neuro Inc (ALZN) have led to the company’s beta value being reach -0.28 cents.

A new trading day began on Monday, with Alzamend Neuro Inc (NASDAQ: ALZN) stock price down -8.62% from the previous day of trading, before settling in for the closing price of $3.83. ALZN’s price has ranged from $3.06 to $135.54 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Meanwhile, its annual earnings per share averaged 89.05%. With a float of $0.77 million, this company’s outstanding shares have now reached $0.80 million.

In an organization with 7 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 66.67%, operating margin of -5528.78%, and the pretax margin is -5553.72%.

Alzamend Neuro Inc (ALZN) Insider and Institutional Ownership

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Alzamend Neuro Inc is 4.22%, while institutional ownership is 0.88%. The most recent insider transaction that took place on May 12 ’25, was worth 6,138. In this transaction Director of this company sold 1,213 shares at a rate of $5.06, taking the stock ownership to the 8,260 shares. Before that another transaction happened on May 12 ’25, when Company’s Director sold 11 for $5.28, making the entire transaction worth $58. This insider now owns 1,843 shares in total.

Alzamend Neuro Inc (ALZN) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.69 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 89.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 61.95% during the next five years compared to -11.45% drop over the previous five years of trading.

Alzamend Neuro Inc (NASDAQ: ALZN) Trading Performance Indicators

Here are Alzamend Neuro Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.44.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -27.58, a number that is poised to hit -3.38 in the next quarter and is forecasted to reach -10.98 in one year’s time.

Technical Analysis of Alzamend Neuro Inc (ALZN)

Let’s dig in a bit further. During the last 5-days, its volume was 16.21 million. That was better than the volume of 0.88 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.96%. Additionally, its Average True Range was 0.87.

During the past 100 days, Alzamend Neuro Inc’s (ALZN) raw stochastic average was set at 5.14%, which indicates a significant decrease from 8.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 283.98% in the past 14 days, which was higher than the 134.68% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.21, while its 200-day Moving Average is $11.57. However, in the short run, Alzamend Neuro Inc’s stock first resistance to watch stands at $3.77. Second resistance stands at $4.05. The third major resistance level sits at $4.19. If the price goes on to break the first support level at $3.36, it is likely to go to the next support level at $3.23. The third support level lies at $2.95 if the price breaches the second support level.

Alzamend Neuro Inc (NASDAQ: ALZN) Key Stats

With a market capitalization of 2.81 million, the company has a total of 801K Shares Outstanding. Currently, annual sales are 0 K while annual income is -9,950 K. The company’s previous quarter sales were 0 K while its latest quarter income was -1,040 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.